Sleep Medicine
Volume 4, Issue 2 , Pages 121-132 , March 2003

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

  • The International Restless Legs Syndrome Study Group

Received 11 June 2002 ,Revised 22 October 2002 ,Accepted 7 December 2002.

References 

  1. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep. 1994;17(8):739–743
  2. Phillips B, Young T, Finn L, et al.  Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137–2141
  3. Rothdach AJ, Trenkwalder C, Haberstock J, et al.  Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54(5):1064–1068
  4. Chesson AL, Wise M, Davila D, et al.  Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999;22(7):961–968
  5. Hening W, Allen R, Earley C, et al.  The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999;22(7):970–999
  6. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200–203
  7. Wagner ML, Walters AS, Coleman RG, et al.  Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep. 1996;19(1):52–58
  8. Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology. 1998;51(6):1599–1602
  9. Wetter TC, Stiasny K, Winkelmann J, et al.  A randomized controlled study of pergolide in patients with restless legs syndrome (see comments). Neurology. 1999;52(5):944–950
  10. Walters AS, Wagner ML, Hening WA, et al.  Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16(4):327–332
  11. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology. 1999;52(5):938–943
  12. Stiasny K, Robbecke J, Schuler P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline – an open clinical trial. Sleep. 2000;23(3):349–354
  13. Montplaisir J, Boucher S, Poirier G, et al.  Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–65
  14. Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. Clin Neurophysiol. 1999;110(7):1168–1174
  15. The International Restless Legs Syndrome Study Group (Arthur S. Walters MD – Group Organizer and Correspondent) . Towards a better definition of the restless legs syndrome. Mov Disord. 1995;10:634–642
  16. Becker PM, Ondo W, Sharon D. Encouraging initial response of restless legs syndrome to pramipexole (see comments). Neurology. 1998;51(4):1221–1223
  17. Ondo W. Ropinirole for restless legs syndrome (see comments). Mov Disord. 1999;14(1):138–140
  18. Trenkwalder C, Brandenburg U, Hundemer H-P, et al.  A randomized long-term placebo-controlled multicenter trial of pergolide in the treatment of RLS – the PEARLS-Study (abstract). Neurology. 2001;56(Suppl 3):A5
  19. Hening WA, Walters AS, Rosen R, et al.  The international RLS study group rating scale: a reliable and valid instrument for assessing severity of the restless legs syndrome. Neurology. 2001;56(Suppl 3):A4
  20. Kaiser HF, Rice J. Little Jiffy Mark IV. Educ Psychol Measure. 1974;34:111–117
  21. Sharma S. Applied multivariate techniques. New York: Wiley; 1996;
  22. Gorsuch RL. Factor analysis. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983;
  23. Cronbach LJP. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334
  24. Nunnally JCJ. Psychometric theory. 2nd ed.. New York: McGraw-Hill; 1978;
  25. Guyatt GH, Walter S, Norman GJCD. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis. 1987;40(2):171–178
  26. Hays R, Anderson R, Reviki DA. Assessing reliability and validity of measurement in clinical trials. In:  Staquet MJ,  Hays RD,  Fayers PM editor. Quality of life assessment in clinical trials. New York: Oxford University Press; 1998;
  27. Campbell DT, Fiske JL. Convergent and discriminant validation by the multitrait multimethod matrix. Psychol Bull. 1959;56:85–105
  28. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Measure. 1973;33:613–619
  29. Trenkwalder C, Hening WA, Walters AS, et al.  Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14(1):102–110
  30. Hening WA, Walters AS, Wagner M, et al.  Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22(7):901–912
  31. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed.. New York: Oxford University Press; 1995;
  32. Allen RP, Earley CJ. Validation of the Johns Hopkins restless legs severity scale. Sleep Med. 2001;2(3):239–242
  33. Sun ER, Chen CA, Ho G, et al.  Iron and the restless legs syndrome. Sleep. 1998;21(4):371–377
  34. Allen RP, Barker PB, Wehrl F, et al.  MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263–265

PII: S1389-9457(02)00258-7

doi: 10.1016/S1389-9457(02)00258-7

Sleep Medicine
Volume 4, Issue 2 , Pages 121-132 , March 2003

Article Tools

* Image Usage & Resolution